EUVIMEDOpdag EUVIMED
Beobachtungsstudie

Evaluation of the safety and efficacy of the Axiostat® dressing device to achieve radial artery access hemostasis: The R3A study

Ariel Nakache, Arthur Darmon, Antoine Molho, Matthieu Steinecker, Mohammed Nejjari, Franck Digne iD

Catheterization and Cardiovascular Interventions · 2024

DOI: 10.1002/ccd.31129 ↗

At a glance

Beobachtungsstudie in Catheterization and Cardiovascular Interventions, 2024. Written by Ariel Nakache and 5 co-authors. Institution: Cardiology Department, Centre Cardiologique du Nord, Saint Denis, France. Major MEDLINE topics: Radial Artery, Hemostatic Techniques, Punctures, Catheterization, Peripheral. Cited 3 times so far (Crossref); 27 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Radial access is the default approach in interventional cardiology. The Axiostat® surgical hemostatic dressing, using chitosan as its active component, has demonstrated potential in accelerating blood clotting. This study aims to assess the efficacy and the safety of the Axiostat® dressing in achieving hemostasis in patients undergoing transradial coronary angioplasty (TRCA).

Methods

This prospective, single‐center observational study, conducted in 2022, enrolled consecutive patients undergoing TRCA, with a target of 150 participants. The primary outcome was the success rate of radial artery hemostasis at 120 min, without bleeding necessitating immediate re‐compression. The secondary outcome included Axiostat® performance at 24 h and 30 days Postprocedure.

Results

The study was terminated prematurely for ethical and patient safety reasons, after inclusion of 41 consecutive TRCA patients due to an unexpectedly high radial artery thrombosis rate (19.5%, n = 8/41) observed 24 h Postprocedure. The success rate of radial hemostasis with the Axiostat® dressing was 78.0%. Procedural details and patient characteristics were comparable between successful Axiostat® removal and device failure cases.

Conclusion

The use of the Axiostat® dressing to achieve hemostasis after TRCA is effective but is associated with an unexpectedly high incidence of radial thrombosis. Our results should encourage caution in the future evaluation and use of this device for radial artery compression following TRCA.

Subjects

MeSH terms (MEDLINE)

Radial ArteryHemostatic TechniquesPuncturesCatheterization, PeripheralEquipment DesignHemorrhageHumansProspective StudiesMaleFemaleAgedMiddle AgedTreatment OutcomeTime FactorsChitosanHemostaticsRisk FactorsPercutaneous Coronary InterventionBandagesThrombosis

Author keywords

axiostat hemostatic dressingradial artery occlusiontransradial catheterization

Substances

ChitosanHemostatics

Authors and institutions

  • Cardiology Department, Centre Cardiologique du Nord, Saint Denis, France.

ORCID profiles: Franck Digne

Cite

APA

Nakache, A., Darmon, A., Molho, A., Steinecker, M., Nejjari, M., & Digne, F. (2024). Evaluation of the safety and efficacy of the Axiostat® dressing device to achieve radial artery access hemostasis: The R3A study. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31129

Vancouver

Nakache A, Darmon A, Molho A, Steinecker M, Nejjari M, Digne F. Evaluation of the safety and efficacy of the Axiostat® dressing device to achieve radial artery access hemostasis: The R3A study. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.31129

BibTeX
@article{Nakache2024,
  author = {Nakache, Ariel and Darmon, Arthur and Molho, Antoine and Steinecker, Matthieu and Nejjari, Mohammed and Digne, Franck},
  title = {Evaluation of the safety and efficacy of the Axiostat® dressing device to achieve radial artery access hemostasis: The R3A study},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2024},
  doi = {10.1002/ccd.31129}
}
Start for free →